Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

The Effect of Rifampicin on the Pharmacokinetics of Intracellular Tenofovir-diphosphate and Tenofovir When Coadministered With Tenofovir Alafenamide Fumarate During the Maintenance Phase of Tuberculosis Treatment in TB/HIV-1 Coinfected Participants

Professor Francois Venter · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
pharmacokineticstuberculosis
hiv-1-infection, tuberculosis, rifampicin, rif/inh, tenofovir alafenamide fumarate (taf), pharmacokinetics, intracellular tenofovir-diphosphate, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 894286
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.